OBJECTIVE: To study the safe use of Dilapan at term for ripening the unfavorable cervix in an outpatient setting. STUDY DESIGN: Prospective review of cervical ripening with Dilapan in women at term gestation. Such women were assigned to either outpatient or inpatient cervical ripening with Dilapan. RESULTS: Twenty-one patients were assigned to each group. The length of induction was similar between women who had ambulatory cervical ripening and hospitalized patients (11 +/- 7 vs. 14 +/- 7 hours, respectively), and the rates of chorioamnionitis, endometritis and nonreassuring fetal heart rate tracings were also similar. However, the average length of hospitalization was significantly shorter for those who had ambulatory ripening as compared to those who were hospitalized (51 +/- 27 vs. 70 +/- 20 hours, respectively; P < .0007). CONCLUSION: The use of Dilapan for cervical ripening at term in an ambulatory setting is safe and effective and may decrease the overall hospitalization time and cost.
RCT Entities:
OBJECTIVE: To study the safe use of Dilapan at term for ripening the unfavorable cervix in an outpatient setting. STUDY DESIGN: Prospective review of cervical ripening with Dilapan in women at term gestation. Such women were assigned to either outpatient or inpatient cervical ripening with Dilapan. RESULTS: Twenty-one patients were assigned to each group. The length of induction was similar between women who had ambulatory cervical ripening and hospitalized patients (11 +/- 7 vs. 14 +/- 7 hours, respectively), and the rates of chorioamnionitis, endometritis and nonreassuring fetal heart rate tracings were also similar. However, the average length of hospitalization was significantly shorter for those who had ambulatory ripening as compared to those who were hospitalized (51 +/- 27 vs. 70 +/- 20 hours, respectively; P < .0007). CONCLUSION: The use of Dilapan for cervical ripening at term in an ambulatory setting is safe and effective and may decrease the overall hospitalization time and cost.
Authors: David A Crosby; Claire O'Reilly; Helen McHale; Fionnuala M McAuliffe; Rhona Mahony Journal: Ir J Med Sci Date: 2017-12-21 Impact factor: 1.568
Authors: Shrikant Bollapragada; Fiona Mackenzie; John Norrie; Stavros Petrou; Margaret Reid; Ian Greer; Inass Osman; Jane E Norman Journal: BMC Pregnancy Childbirth Date: 2006-07-25 Impact factor: 3.007